Literature DB >> 25794265

Dual Therapeutic Effects of C-10068, a Dextromethorphan Derivative, Against Post-Traumatic Nonconvulsive Seizures and Neuroinflammation in a Rat Model of Penetrating Ballistic-Like Brain Injury.

Xi-Chun May Lu1, Deborah A Shear1, Philip B Graham2, Gary W Bridson2, Vinita Uttamsingh2, Zhiyong Chen1, Lai Yee Leung1, Frank C Tortella1.   

Abstract

Post-traumatic seizures can exacerbate injurious outcomes of severe brain trauma, yet effective treatments are limited owing to the complexity of the pathology underlying the concomitant occurrence of both events. In this study, we tested C-10068, a novel deuterium-containing analog of (+)-N-methyl-3-ethoxymorphinan, in a rat model of penetrating ballistic-like brain injury (PBBI) and evaluated the effects of C-10068 on PBBI-induced nonconvulsive seizures (NCS), acute neuroinflammation, and neurofunctional outcomes. NCS were detected by electroencephalographic monitoring. Neuroinflammation was evaluated by immunohistochemical markers, for example, glial fibrillary acidic protein and major histocompatibility complex class I, for activation of astrocytes and microglia, respectively. Neurofunction was tested using rotarod and Morris water maze tasks. Three infusion doses of C-10068 (1.0, 2.5, and 5.0 mg/kg/h × 72 h) were tested in the antiseizure study. Neuroinflammation and neurofunction were evaluated in animals treated with 5.0 mg/kg/h × 72 h C-10068. Compared to vehicle treatment, C-10068 dose dependently reduced PBBI-induced NCS incidence (40-50%), frequency (20-70%), and duration (30-82%). The most effective antiseizure dose of C-10068 (5.0 mg/kg/h × 72 h) also significantly attenuated hippocampal astrocyte activation and perilesional microglial reactivity post-PBBI. Within C-10068-treated animals, a positive correlation was observed in reduction in NCS frequency and reduction in hippocampal astrocyte activation. Further, C-10068 treatment significantly attenuated astrocyte activation in seizure-free animals. However, C-10068 failed to improve PBBI-induced motor and cognitive functions with the dosing regimen used in this study. Overall, the results indicating that C-10068 exerts both potent antiseizure and antiinflammatory effects are promising and warrant further investigation.

Entities:  

Keywords:  C-10068; EEG; dextromethorphan; neuroinflammation; nonconvulsive seizures; penetrating brain injury

Mesh:

Substances:

Year:  2015        PMID: 25794265      PMCID: PMC4593875          DOI: 10.1089/neu.2014.3766

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  59 in total

1.  An astrocytic basis of epilepsy.

Authors:  Guo-Feng Tian; Hooman Azmi; Takahiro Takano; Qiwu Xu; Weiguo Peng; Jane Lin; NancyAnn Oberheim; Nanhong Lou; Xiaohai Wang; H Ronald Zielke; Jian Kang; Maiken Nedergaard
Journal:  Nat Med       Date:  2005-08-14       Impact factor: 53.440

2.  Guidelines for the management of severe traumatic brain injury. XIII. Antiseizure prophylaxis.

Authors:  Susan L Bratton; Randall M Chestnut; Jamshid Ghajar; Flora F McConnell Hammond; Odette A Harris; Roger Hartl; Geoffrey T Manley; Andrew Nemecek; David W Newell; Guy Rosenthal; Joost Schouten; Lori Shutter; Shelly D Timmons; Jamie S Ullman; Walter Videtta; Jack E Wilberger; David W Wright
Journal:  J Neurotrauma       Date:  2007       Impact factor: 5.269

3.  Characterization of a new rat model of penetrating ballistic brain injury.

Authors:  Anthony J Williams; Jed A Hartings; X-C May Lu; Michael L Rolli; Jitendra R Dave; Frank C Tortella
Journal:  J Neurotrauma       Date:  2005-02       Impact factor: 5.269

Review 4.  Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders.

Authors:  G Debonnel; C de Montigny
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

5.  Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons.

Authors:  K L Klette; Y Lin; L E Clapp; M A DeCoster; J E Moreton; F C Tortella
Journal:  Brain Res       Date:  1997-05-09       Impact factor: 3.252

6.  Valproate therapy for prevention of posttraumatic seizures: a randomized trial.

Authors:  N R Temkin; S S Dikmen; G D Anderson; A J Wilensky; M D Holmes; W Cohen; D W Newell; P Nelson; A Awan; H R Winn
Journal:  J Neurosurg       Date:  1999-10       Impact factor: 5.115

7.  Early and late posttraumatic seizures in traumatic brain injury rehabilitation patients: brain injury factors causing late seizures and influence of seizures on long-term outcome.

Authors:  I Asikainen; M Kaste; S Sarna
Journal:  Epilepsia       Date:  1999-05       Impact factor: 5.864

8.  Ethosuximide and phenytoin dose-dependently attenuate acute nonconvulsive seizures after traumatic brain injury in rats.

Authors:  Andrea Mountney; Deborah A Shear; Brittney Potter; Sean R Marcsisin; Jason Sousa; Victor Melendez; Frank C Tortella; Xi-Chun M Lu
Journal:  J Neurotrauma       Date:  2013-10-18       Impact factor: 5.269

Review 9.  Overview of studies to prevent posttraumatic epilepsy.

Authors:  Ettore Beghi
Journal:  Epilepsia       Date:  2003       Impact factor: 5.864

Review 10.  Dextromethorphan and neuromodulation: old drug coughs up new activities.

Authors:  F C Tortella; M Pellicano; N G Bowery
Journal:  Trends Pharmacol Sci       Date:  1989-12       Impact factor: 14.819

View more
  6 in total

1.  Amelioration of Penetrating Ballistic-Like Brain Injury Induced Cognitive Deficits after Neuronal Differentiation of Transplanted Human Neural Stem Cells.

Authors:  Markus S Spurlock; Aminul I Ahmed; Karla N Rivera; Shoji Yokobori; Stephanie W Lee; Pingdewinde N Sam; Deborah A Shear; Michael P Hefferan; Thomas G Hazel; Karl K Johe; Shyam Gajavelli; Frank C Tortella; Ross M Bullock
Journal:  J Neurotrauma       Date:  2017-03-23       Impact factor: 5.269

2.  Comprehensive Evaluation of Neuroprotection Achieved by Extended Selective Brain Cooling Therapy in a Rat Model of Penetrating Ballistic-Like Brain Injury.

Authors:  Xi-Chun May Lu; Deborah A Shear; Ying Deng-Bryant; Lai Yee Leung; Guo Wei; Zhiyong Chen; Frank C Tortella
Journal:  Ther Hypothermia Temp Manag       Date:  2015-12-18       Impact factor: 1.286

Review 3.  Post-Traumatic Epilepsy and Comorbidities: Advanced Models, Molecular Mechanisms, Biomarkers, and Novel Therapeutic Interventions.

Authors:  Victoria M Golub; Doodipala Samba Reddy
Journal:  Pharmacol Rev       Date:  2022-04       Impact factor: 25.468

4.  Enhanced setup for wired continuous long-term EEG monitoring in juvenile and adult rats: application for epilepsy and other disorders.

Authors:  Yasser Medlej; Rita Asdikian; Lara Wadi; Houssein Salah; Laura Dosh; Rabih Hashash; Nabil Karnib; Mohammad Medlej; Hala Darwish; Firas Kobeissy; Makram Obeid
Journal:  BMC Neurosci       Date:  2019-03-04       Impact factor: 3.288

5.  Oral Dextromethorphan for the Treatment of Diabetic Macular Edema: Results From a Phase I/II Clinical Study.

Authors:  David J Valent; Wai T Wong; Emily Y Chew; Catherine A Cukras
Journal:  Transl Vis Sci Technol       Date:  2018-12-17       Impact factor: 3.283

6.  Penetrating Ballistic Brain Injury Produces Acute Alterations in Sleep and Circadian-Related Genes in the Rodent Cortex: A Preliminary Study.

Authors:  Andrea Mountney; Jennifer Blaze; Zhaoyu Wang; Michelle Umali; William Jesse Flerlage; Jacqueline Dougherty; Yongchao Ge; Deborah Shear; Fatemeh Haghighi
Journal:  Front Neurol       Date:  2021-10-21       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.